Furthermore, the regressing tumor exhibited a rise in both CD163:CD68 and FoxP3:CD4 ratios, suggesting that the inflammation driving STR was associated with an upregulation in immunosuppressive M2 macrophages and regulatory T-cells (Tregs), respectively (Fig. 2). The gene discussed is CD4; the disease is neoplasm.